Asset Details
Do you wish to reserve the book?
Katayama syndrome
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Katayama syndrome
Do you wish to request the book?
Katayama syndrome
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Katayama syndrome
2007
Overview
Katayama syndrome is an early clinical manifestation of schistosomiasis that occurs several weeks post-infection with
Schistosoma spp (trematode) worms. Because of this temporal delay and its non-specific presentation, it is the form of schistosomiasis most likely to be misdiagnosed by travel medicine physicians and infectious disease specialists in non-endemic countries. Katayama syndrome appears between 14–84 days after non-immune individuals are exposed to first schistosome infection or heavy reinfection. Disease onset appears to be related to migrating schistosomula and egg deposition with individuals typically presenting with nocturnal fever, cough, myalgia, headache, and abdominal tenderness. Serum antibodies and schistosome egg excretion often substantiate infection if detected. Diffuse pulmonary infiltrates are found radiologically, and almost all cases have eosinophilia and a history of water contact 14–84 days before presentation of clinical symptoms; patients respond well to regimens of praziquantel with and without steroids. Artemisinin treatment given early after exposure may decrease the risk of the syndrome.
Publisher
Elsevier Ltd,Lancet Publishing Group,Elsevier Limited
Subject
/ Artemisinins - therapeutic use
/ Biological and medical sciences
/ Diseases caused by trematodes
/ Humans
/ Praziquantel - therapeutic use
/ Schistosoma - growth & development
/ Schistosoma - isolation & purification
/ Schistosomiasis - drug therapy
/ Schistosomiasis - parasitology
/ Schistosomiasis - physiopathology
/ Schistosomicides - therapeutic use
